Skip to main content

Altered expression of p53 and Rb tumor suppressor genes in lung cancer

Buy Article:

$42.00 + tax (Refund Policy)

The aim of this study was to evaluate the frequency of altered expression of pRb and p53, two well known tumor suppressor genes, in lung cancer and to relate it to the prognosis of the patients affected by this type of neoplasm. We evaluated 68 specimens from patients with surgically resected lung cancer. Of the 68 neoplasms investigated, 29 (42.6%) displayed a positive nuclear staining for p53. Ten (15.7%) of the investigated tumors showed absence of pRb nuclear immunoreactivity. p53 overexpression correlated statistically with short-term survival. On the other hand no statistically significant difference (p=ns) in survival was detected between pRb producers and nonproducer patients. In addition, we divided our specimens into two groups according to the p53 and pRb status. The first group consisted of all the p53(+) pRb specimens. The second group contained all the remaining specimens. Comparison between these two groups did not reveal any significant difference in overall survival time. These findings confirm that only p53 overexpression can be considered an independent prognostic factor in lung cancer.

Document Type: Research Article

Affiliations: THOMAS JEFFERSON UNIV,DEPT PATHOL,PHILADELPHIA,PA 19107. THOMAS JEFFERSON UNIV,DEPT ANAT & CELL BIOL,PHILADELPHIA,PA 19107. THOMAS JEFFERSON UNIV,KIMMEL CANC INST,PHILADELPHIA,PA 19107. UNIV NAPLES 2,IST TISIOL & MALATTIE RESP S MARCATILI,NAPLES,ITALY. UNIV NAPLES 2,IST ANAT TOPOG,NAPLES,ITALY. UNIV NAPLES 2,IST ANAT & ISTOL PATOL,NAPLES,ITALY.

Publication date: 01 September 1996

More about this publication?
  • The International Journal of Oncology provides an international forum for the publication of the latest, cutting-edge research in the broad area of oncology and cancer treatment. The journal accepts original high quality works and reviews on all aspects of oncology research including carcinogenesis, metastasis, epidemiology, chemotherapy and viral oncology. Through fair and efficient peer review, the journal is dedicated to publishing top tier research in the field, offering authors rapid publication as well as high standards of copy-editing and production. The International Journal of Oncology is published on a monthly basis in both print and early online.
  • Editorial Board
  • Information for Authors
  • Submit a Paper
  • Subscribe to this Title
  • Information for Advertisers
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content